Adamax is structurally derived from Semax, a well‑studied ACTH(4–10) analog with nootropic properties. Semax increases brain‑derived neurotrophic factor (BDNF) expression and enhances TrkB receptor sensitivity in the hippocampus[4][5], promoting neuroplasticity, synaptic formation, and neuronal survival. The peptide modulates neurotransmitter systems (dopamine, serotonin) and activates intracellular signaling cascades (cAMP/CREB pathways), leading to improved memory, learning, and stress resilience[6]. Adamax’s adamantane moiety confers greater lipophilicity and enzymatic stability than Semax[3], enabling more efficient blood–brain barrier crossing and prolonged in vivo half‑life. This structural enhancement amplifies neuroprotective effects and reduces dosing frequency requirements. Preclinical data suggest 2–3 times greater efficacy in cognitive and endurance outcomes compared to standard Semax[3].